Skip to main content
Home
Articles
Latest Issue
Issue Archive
Special Issues
Supplements
Categories
Conference Correspondent
ASH 2023 - CLL
SABCS 2023 - HR+/HER2- MBC
Web Exclusives
All Web Exclusives
Interview with the Innovators
Rapid Reactions
FDA Oncology Update
Videos
Press Releases
Gastrointestinal Cancer Monthly Minutes
For Authors
Author Guidelines
Symptom Management Overview
Letters to the Editor Instructions
Join Our Peer Review
Submit a Manuscript
About
About JHOP
Contact Us
Editorial Policies
Peer-Review Process
About the Editors
Editorial Board
Editorial Process
Advertising Policy
Advertise
Subscribe
Home
Articles
Latest Issue
Issue Archive
Special Issues
Supplements
Categories
Conference Correspondent
ASH 2023 - CLL
SABCS 2023 - HR+/HER2- MBC
Web Exclusives
All Web Exclusives
Interview with the Innovators
Rapid Reactions
FDA Oncology Update
Videos
Press Releases
Gastrointestinal Cancer Monthly Minutes
For Authors
Author Guidelines
Symptom Management Overview
Letters to the Editor Instructions
Join Our Peer Review
Submit a Manuscript
About
About JHOP
Contact Us
Editorial Policies
Peer-Review Process
About the Editors
Editorial Board
Editorial Process
Advertising Policy
Advertise
Online First
Online First
Tivdak First Antibody–Drug Conjugate FDA Approved for Recurrent or Metastatic Cervical Cancer
Read More
Online First
Exkivity Novel Oral Targeted Therapy Approved for Metastatic NSCLC with EGFR Exon 20 Insertion Mutations
Read More
Online First
Welireg FDA Approved for 3 Tumor Types Associated with von Hippel-Lindau Disease
Read More
Online First
Rezurock Novel Oral Therapy FDA Approved for Chronic Graft-Versus-Host Disease
Read More
Online First
Jakafi a New Treatment Option for Chronic Graft-Versus-Host Disease
Read More
Online First
Cabometyx Receives FDA Approval for Differentiated Thyroid Cancer
Read More
Online First
Nivolumab First Immunotherapy Approved for Adjuvant Treatment of Urothelial Carcinoma
Read More
Online First
Jemperli Another Therapy Approved for Patients with dMMR Recurrent or Advanced Solid Tumors
Read More
Online First
Lenvima plus Keytruda a New Combination Approved for Advanced Renal-Cell Carcinoma
Read More
Online First
Successful Treatment of Chronic Myeloid Leukemia with Low-Dose Nilotinib
Read More
1
2
3
4
5
Page 2 of 10
Results 11 - 20 of 94